Business Context and Reporting Period
Company: Keros Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 18, 2026
Reporting Period: Single event date (February 18, 2026)
This filing serves as a Regulation FD disclosure to announce upcoming corporate presentations by the Company's President and Chief Executive Officer, Jasbir Seehra, at three major healthcare conferences.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate events and does not contain financial statements or performance metrics.
Material Changes
No material financial changes or operational updates are reported in this filing. The document solely discloses the schedule of upcoming investor relations activities.
Guidance, Outlook, and Management Commentary
Upcoming Presentations:
- Oppenheimer 36th Annual Healthcare Life Sciences Conference: Wednesday, February 25, 2026, at 11:20 a.m. Eastern time (Corporate Presentation).
- TD Cowen 46th Annual Health Care Conference: Tuesday, March 3, 2026, at 9:50 a.m. Eastern time (Fireside Chat).
- Leerink Partners Global Healthcare Conference: Tuesday, March 10, 2026, at 1:00 p.m. Eastern time (Fireside Chat).
Legal Disclaimer: The information furnished in this report and the accompanying press release (Exhibit 99.1) is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific dates and times of the three announced conference presentations.
- Review the attached press release (Exhibit 99.1) for any additional details on the presentation topics.
- Monitor the Company's investor relations website for webcast links or slide decks following the conference dates.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial status.